Last $6.75 USD
Change Today +0.28 / 4.33%
Volume 487.5K
XNPT On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 05/17/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William G. Harris

Chief Financial Officer, Principal Accounting Officer and Senior Vice President of Finance, Xenoport, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

53$731,354
As of Fiscal Year 2012

Background*

Mr. William G. Harris has been Senior Vice President of Finance and Chief Financial Officer of Xenoport, Inc. since November 2001 and serves as its Principal Accounting Officer. From July 1996 to January 2000, Mr. Harris served as Vice President and Chief Financial Officer of Coulter Pharmaceutical. He served as Senior Vice President of Coulter Pharmaceutical since February 2000. From July 1992 to July 1996, Mr. Harris served as Director of Finance at Gilead Sciences, ...

Read Full Background

Corporate Headquarters*

3410 Central Expressway
Santa Clara, California 95051

United States

Phone: 408-616-7200
Fax: --

Board Members Memberships*

2007-N/A
Former Director and Chairman of Audit Committee

Education*

BA
University of California - San Diego
MBA
Santa Clara University Graduate School of Business

Other Affiliations*

Annual Compensation*

Salary$360,190
Total Annual Compensation$360,190

Stock Options*

Restricted Stock Awards$130,200
All Other Compensation$5,414
Exercisable Options229,247
Exercisable Options Value$277,827
Unexercisable Options60,585
Unexercisable Options Value$79,319
Total Value of Options$357,145
Total Number of Options289,832

Total Compensation*

Total Annual Cash Compensation$516,884
Total Short Term Compensation$360,190
Other Long Term Compensation$135,614
Total Calculated Compensation$731,354
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XNPT:US $6.75 USD +0.28

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael S. Anderson Chief Executive Officer and Director
Flamel Technologies SA
--
G. Kelly Martin Chief Executive Officer and Executive Director
Elan Corporation, plc
$2.1M
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$567.0K
Peter Grant Chief Executive Officer, Chief Financial Officer, Finance Director and Executive Director
SkyePharma plc
245.0K GBP
Arun Sawhney B.Com., P.G.D.B.M.Managing Director, Chief Executive Officer, Executive Director, Member of Shareholders/Investors Grievance & Share Transfer Committee and Member of Science Committee
Ranbaxy Laboratories Ltd.
89.2M
Compensation as of Fiscal Year --.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XENOPORT INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.